Mutation of PTEN in glioma stem/progenitor cells: a case report

Cancer Genetics and Cytogenetics

Volumn 195, Issue 2, 2009, Pages 183.e1-183.e7

  Zhao, Yaodong ^a   Huang, Qiang ^a   Wang, Aidong ^a   Dong, Jun ^a   Lan, Qing ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; CANCER STEM CELL; CASE REPORT; CELL ISOLATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 71149099149     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.07.006     Document Type: Letter

References (10)

1. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., and Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104 (2007) 973-978
2. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
3. Marino S., Krimpenfort P., Leung C., van der Korput H.A., Trapman J., Camenisch I., Berns A., and Brandner S. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 129 (2002) 3513-3522
4. Wang X., and Jiang X. PTEN: a default gate-keeping tumor suppressor with a versatile tail. Cell Res 18 (2008) 807-816
5. Wang S., Garcia A.J., Wu M., Lawson D.A., Witte O.N., and Wu H. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 103 (2006) 1480-1485
6. Yilmaz O.H., Valdez R., Theisen B.K., Guo W., Ferguson D.O., Wu H., and Morrison S.J. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441 (2006) 475-482
7. Huang Q., Zhang Q.B., Dong J., Wu Y.Y., Shen Y.T., Zhao Y.D., Zhu Y.D., Diao Y., Wang A.D., and Lan Q. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. BMC Cancer 8 (2008) 304
8. Chen H., Huang Q., Dong J., Zhai D.Z., Wang A.D., and Lan Q. Overexpression of CDC2/CyclinB1 in gliomas and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo. BMC Cancer 8 (2008) 29
9. Maehama T., and Dixon J.E. The tumor suppressor PTEN/ MMAC1 dephosphorylates the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273 (1998) 13375-13378
10. Campbell R.B., Liu F., and Ross A.H. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. J Biol Chem 278 (2003) 33617-33620